DCM Shriram Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
DCMSHRIRAM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.4 pts more than Nifty Smallcap 250 and 0.3 pts less than its Diversified peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
DCM Shriram reported steady Q1 FY26 results. Standalone revenue from operations rose to Rs 3,348.85 crore from Rs 3,012.85 crore a year ago (~11% growth), while standalone profit after tax was Rs 96.73 crore vs Rs 93.66 crore. Consolidated revenue grew to Rs 3,455.18 crore (~12% YoY) with PAT of Rs 113.82 crore vs Rs 100.30 crore (~13% YoY). Consolidated EBIDTA improved to Rs 325.73 crore, and operating margin expanded from 8.65% to 9.34%. The company recently acquired 53% of DNV Global (May 2025) and signed a binding agreement to buy 100% of Hindusthan Speciality Chemicals. Debt-equity ratio remains comfortable at 0.21–0.22x. Auditors Deloitte Haskins & Sells LLP issued a clean limited review with no qualifications.
Modest revenue and profit growth with margin expansion signals steady operational performance. The two acquisitions could be EPS-accretive over time, but near-term integration costs may weigh. Overall a stable, in-line quarter for shareholders.